Evidence map›Paper›PMID 34574070›Full record

ArticleDiagnostics (Basel, Switzerland)2021

C-Reactive Protein for the Early Assessment of Non-Malarial Febrile Patients: A Retrospective Diagnostic Study.

Giulia Bertoli, Cristina Mazzi, Niccolò Ronzoni, Ronaldo Silva, Michele Spinicci, Marco Pozzi, Pietro Sponga, Andrea Aiello, Tamara Ursini, Alessandro Bartoloni and 3 more

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.2field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 2 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 3 countries.

Giulia BertoliDepartment of Infectious, Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, 37024 Verona, Italy.ORCID 0000-0003-4175-1620
Cristina MazziDepartment of Infectious, Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, 37024 Verona, Italy.
Niccolò RonzoniDepartment of Infectious, Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, 37024 Verona, Italy.
Ronaldo SilvaDepartment of Infectious, Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, 37024 Verona, Italy.ORCID 0000-0002-2852-2287
Michele SpinicciDepartiment di Medicina Sperimentale e Clinica, Università degli Studi di Firenze, 50121 Firenze, Italy.ORCID 0000-0002-5377-7118
Marco PozziDepartiment di Medicina Sperimentale e Clinica, Università degli Studi di Firenze, 50121 Firenze, Italy.
Pietro SpongaDepartiment di Medicina Sperimentale e Clinica, Università degli Studi di Firenze, 50121 Firenze, Italy.
Andrea AielloDepartiment di Medicina Sperimentale e Clinica, Università degli Studi di Firenze, 50121 Firenze, Italy.
Tamara UrsiniDepartment of Infectious, Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, 37024 Verona, Italy.
Alessandro BartoloniDepartiment di Medicina Sperimentale e Clinica, Università degli Studi di Firenze, 50121 Firenze, Italy.ORCID 0000-0001-9758-1523
Piero OlliaroFIND (Foundation for Innovative Diagnostics), 1202 Geneva, Switzerland.
Zeno BisoffiDepartment of Infectious, Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, 37024 Verona, Italy.ORCID 0000-0001-9530-8742
Dora BuonfrateDepartment of Infectious, Tropical Diseases and Microbiology, IRCCS Sacro Cuore Don Calabria Hospital, Negrar di Valpolicella, 37024 Verona, Italy.ORCID 0000-0003-0108-6822
Ospedale Sacro Cuore Don Calabria · ITUniversity of Florence · ITFIND · CHUniversity of Verona · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Biomarkers, especially CRP, have demonstrated their relevance to differentiate viral from bacterial infection, even though a reliable threshold is far to being found. In low- and middle-income countries, affordable and user-friendly rapid diagnostic tests based on biomarkers can be widely adopted to help health workers in the management of non-malarial fever. The primary objective of this study is to assess the best CRP cut-off to distinguish viral from bacterial infections. Other biomarkers were evaluated for the same purpose, alone or in combination with CRP. We retrospectively collected data from two referral hospital departments for infectious and tropical diseases in Italy. Areas under the ROC curve (AUC) were calculated and then compared using the DeLong test. Overall, we included 1193 febrile cases (viral 20.74% vs. bacterial 79.25%). We also collected malaria (

Indexed as

low- and middle-income countriesnon-malarial feverpoint-of-care tests

Identifiers

PMID34574070
PMCPMC8469932
OpenAlexW3199658414

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.